Using a method different from traditional, the US company announced that it had found a vaccine for Covid-19

CBS News quoted the sources as saying, researchers at a laboratory in San Diego said they have developed a vaccine for corona virus (COVID-19) after only 3 hours. If effective, vaccines will be the most effective way to deal with infectious diseases that are causing more than 60,000 infections around the world.

Good news from America

On January 9, Chinese scientists announced the genetic structure of COVID-19 virus. After that, researchers at Inovio and other laboratories around the world immediately began work.

"We use an algorithm we designed, put the viral DNA sequence here and find the vaccine in a short period of time," said Dr. Trevor Smith, Inovio's director of research and development, said. good.

"We are trained to do this, the infrastructure is qualified and the experts are always very supportive," Mr. Smith said. Previously, the company also studied and prepared vaccines for viruses Zika, MERS and Ebola.

To date, Inovio's vaccine has been tested in mice and guinea pigs.

The researchers hope the vaccine will act as a "biological software," helping the human body to produce antibodies that help stop the virus.

"I think the situation is very positive. Inovio has very advanced technologies to make vaccines. This is different from the way we make traditional vaccines," said Dr. Amesh Adalja, a senior scholar at Johns Hopkins University Health Security Center, responded to CBS News.

To date, Inovio's vaccine has been tested in mice and guinea pigs. Soon, the company could test the vaccine on humans in early summer. Inovio said this was a record short period in creating a new vaccine.

The scientists say they feel pressured in time to announce the new vaccine to the public. However, even if all the experiments are successful, the vaccine still needs to undergo medical-standard assessments and a mass production line needs to be established.

Leading researcher of Inovio is currently at WHO to formulate a defense against COVID-19 virus.

Earlier, WHO Director-General Tedros Adhanom Ghebreyesus said there was no vaccine or corona-specific cure yet, but world experts were working to prevent the spread of the deadly virus with a response plan. developed after the Ebola epidemic in West Africa.

"We have started our research and development team to collaborate and share information on how to respond to the disease since early January," Ghebreyesus said at the corona disease forum last week.

Need more time

In addition to Inovio, many other US laboratories are also intensifying research to find vaccines. Still, experts say the most important thing right now is patience.

"Although we see rapid progress in the research of anti-virus vaccines, this is a job that is usually measured in years, not months. We will see the results of vaccine trials, about safety, about whether the vaccine makes antibodies, and finding the right dose . Everything needs to be clear. "

If the vaccine is successfully developed, it could take "about a year" before people can use it widely, Adalja said.

"Vaccine production is one thing, but companies also need to produce vaccines in sufficient quantities to help the immune community, not to mention the mass production process that must be done safely, quickly, and properly. standard. It all takes time. "

To date, at least 1,500 deaths have been attributed to COVID-19. Most cases of infection and death were in China, where the outbreak occurred.

According to the CDC, the symptoms of coronary disease include fever, cough, shortness of breath. Some patients have milder symptoms, but others have severe pneumonia and are at risk of death.

1. Why is the process of creating a vaccine so sluggish despite the corona virus spread?
2. Hot: Publish photos of lungs devoured by corona virus
3. Why does corona virus scare many people even with low death rate?
4. Combining HIV and flu drugs to combat corona virus